Jordan, "Intravenous immunoglobulin suppression of HLA alloAb in highly sensitized transplant candidates and transplantation with a
histoincompatible organ," Transplantation, vol.
Pre-treating
histoincompatible donor bone marrow with a highly selective immunosuppressant improves engraftment rates and reduces the risk of graft-versus-host disease (GVHD), Boston, Mass.
Since then, studies in the fully
histoincompatible rat transplant model of PVG donor to DA recipient have shown that increasing antigen load, by transplanting multiple organs, increases allograft survival rates.